📣 VC round data is live. Check it out!

Pulmuone Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pulmuone and similar public comparables like Xiwang Foodstuffs, Wawel, Watt's SA, Village Farms and more.

Pulmuone Overview

About Pulmuone

Pulmuone Corp is a South Korean company involved in food manufacturing and food material distribution. The company's businesses are production of tofu, bean sprouts, eggs, and noodles; chilled delivery logistics; food service, food material distribution; and manufacture of healthcare foods, also includes mineral water, and fermented milk, concession businesses.


Founded

1984

HQ

South Korea

Employees

N/A

Financials (LTM)

Revenue: $2B
EBITDA: $178M

EV

$964M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pulmuone Financials

Pulmuone reported last 12-month revenue of $2B and EBITDA of $178M.

In the same LTM period, Pulmuone generated $561M in gross profit, $178M in EBITDA, and $17M in net income.


Pulmuone P&L

In the most recent fiscal year, Pulmuone reported revenue of $2B and EBITDA of $182M.

Pulmuone is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 8%, and net margin of 1%.

See analyst estimates for Pulmuone
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$561M$569M$520M$558M$569M
Gross Margin24%25%25%25%25%
EBITDA$178M$182M$150M$183M$182M
EBITDA Margin8%8%7%8%8%
EBIT Margin3%3%2%3%3%
Net Profit$17M$12M$13M$24M$12M
Net Margin1%1%1%1%1%
Net Debt—$461M———

Financial data powered by Morningstar, Inc.

Pulmuone Stock Performance

Pulmuone has current market cap of $284M, and enterprise value of $964M.


Pulmuone's stock price is $7.70.

Pulmuone has an EPS (earnings per share) of $0.34.

See more trading valuation data for Pulmuone
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$964M$284M-0.4%———$0.34

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pulmuone Valuation Multiples

Pulmuone trades at 0.4x EV/Revenue multiple, and 5.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Pulmuone

Pulmuone Financial Valuation Multiples

As of May 10, 2026, Pulmuone has market cap of $284M and EV of $964M.

Pulmuone has a P/E ratio of 17.0x.

LTMLast FY202320242025202620272028
EV/Revenue0.4x0.4x0.5x0.4x0.4x
EV/EBITDA5.4x5.3x6.4x5.3x5.3x
EV/EBIT14.3x15.1x22.7x15.3x15.1x
EV/Gross Profit1.7x1.7x1.9x1.7x1.7x
P/E17.0x22.9x21.3x11.7x22.9x
EV/FCF(12.9x)151.8x21.3x19.0x151.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pulmuone Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pulmuone Margins & Growth Rates

Pulmuone grew revenue by 4% and EBITDA by 3% in the last fiscal year.

In the most recent fiscal year, Pulmuone reported gross margin of 25%, EBITDA margin of 8%, and net margin of 1%.

See estimated margins and future growth rates for Pulmuone

Pulmuone Margins

Last FY202420252026202720282029
Gross Margin25%25%25%24%
EBITDA Margin8%8%8%8%
EBIT Margin3%3%3%3%
Net Margin1%1%1%1%
FCF Margin0%2%0%2%

Pulmuone Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%7%5%4%
Gross Profit Growth4%7%2%4%
EBITDA Growth3%23%(1%)3%
EBIT Growth22%48%1%22%
Net Profit Growth125%81%(49%)125%
FCF Growth617%12%(87%)617%

Data powered by FactSet, Inc. and Morningstar, Inc.

Pulmuone Operational KPIs

Pulmuone's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pulmuone's Rule of X is 19% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Pulmuone
LTMLast FY202320242025202620272028
Rule of 4015%12%———
Bessemer Rule of X26%19%———
S&M Expenses to Revenue—11%12%12%11%
G&A Expenses to Revenue—1%1%1%1%
R&D Expenses to Revenue—1%1%1%1%
Opex to Revenue—22%23%22%22%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pulmuone Competitors

Pulmuone competitors include Xiwang Foodstuffs, Wawel, Watt's SA, Village Farms, Halwani Bros, Bonduelle, Alico, Ottakringer Getraenke, What's Cooking and Easy Holdings Co.

Most Pulmuone public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Xiwang Foodstuffs0.4x—(1.6x)—
Wawel1.1x—5.9x—
Watt's SA0.7x—14.2x—
Village Farms1.2x1.1x5.0x5.1x
Halwani Bros1.4x1.4x10.5x12.2x
Bonduelle0.5x0.5x6.7x6.3x
Alico8.2x16.8x16.1x20.8x
Ottakringer Getraenke1.1x—11.7x—

This data is available for Pro users. Sign up to see all Pulmuone competitors and their valuation data.

Start Free Trial

Pulmuone Investment Activity

Pulmuone has invested in 2 companies to date.

Latest investment by Pulmuone was on December 27th 2022. Pulmuone invested in SIMPLE planet in their $800K Seed round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Pulmuone

SIMPLE planet
YO-KAI EXPRESS
Description
SIMPLE planet is a Copenhagen-based biotech firm developing animal cell-based food ingredients via cellular agriculture. The company produces sustainable fats, proteins, and collagen for meat alternatives using proprietary bioreactor technology. SIMPLE planet collaborates with food manufacturers in Denmark and the Netherlands for scalable production.
YO-KAI EXPRESS is a Sunnyvale-headquartered developer of autonomous vending machines that dispense hot ramen bowls. Founded in 2016, the machines prepare gourmet noodles using fresh ingredients like authentic broths and toppings in under two minutes. Customers select from multiple noodle types and pay via card or mobile code. Units operate in high-traffic locations including airports and malls across California and Hawaii, providing chopsticks, spoons, and protective carriers with each order.
HQ CountrySouth KoreaUnited States
HQ City
Seoul
San Francisco, CA
Deal Date27 Dec 20222 Sep 2022
RoundSeedSeries A
Raised$800K$9M
InvestorsPulmuoneChikaranomoto Holdings Co., Ltd.; Japan Tobacco; Pulmuone
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Pulmuone investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pulmuone

When was Pulmuone founded?Pulmuone was founded in 1984.
Where is Pulmuone headquartered?Pulmuone is headquartered in South Korea.
Is Pulmuone publicly listed?Yes, Pulmuone is a public company listed on Korea Exchange.
What is the stock symbol of Pulmuone?Pulmuone trades under 017810 ticker.
When did Pulmuone go public?Pulmuone went public in 1995.
Who are competitors of Pulmuone?Pulmuone main competitors include Xiwang Foodstuffs, Wawel, Watt's SA, Village Farms, Halwani Bros, Bonduelle, Alico, Ottakringer Getraenke, What's Cooking, Easy Holdings Co.
What is the current market cap of Pulmuone?Pulmuone's current market cap is $284M.
What is the current revenue of Pulmuone?Pulmuone's last 12 months revenue is $2B.
What is the current revenue growth of Pulmuone?Pulmuone revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Pulmuone?Current revenue multiple of Pulmuone is 0.4x.
Is Pulmuone profitable?Yes, Pulmuone is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Pulmuone?Pulmuone's last 12 months EBITDA is $178M.
What is Pulmuone's EBITDA margin?Pulmuone's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Pulmuone?Current EBITDA multiple of Pulmuone is 5.4x.
What is the current FCF of Pulmuone?Pulmuone's last 12 months FCF is ($75M).
What is Pulmuone's FCF margin?Pulmuone's last 12 months FCF margin is (3%).
What is the current EV/FCF multiple of Pulmuone?Current FCF multiple of Pulmuone is (12.9x).
How many companies Pulmuone has acquired to date?Pulmuone hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Pulmuone has invested to date?As of May 2026, Pulmuone has invested in 2 companies.
What was the last Pulmuone investment?On 27th December 2022 Pulmuone invested in SIMPLE planet, participating in a $800K Seed round.
In what companies Pulmuone invested in?Pulmuone invested in YO-KAI EXPRESS and SIMPLE planet.

See public comps similar to Pulmuone

Lists including Pulmuone

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial